Changes in Opioid Marketing Practices After Release of the CDC Guidelines
After the CDC guidelines’ release, total opioid marketing spending and encounters per physician decreased, but spending per encounter subsequently increased.
FDA Safety Warnings and Trends in Testosterone Marketing to Physicians
This article presents an evaluation of testosterone marketing practices around the period of the testosterone label warning by physician specialty and rural vs urban primary care service area.
